CREBBP and thrombocytosis disease: Intriguingly, Crebbp+/- LSK recipients did not have an obvious myeloproliferative phenotype, such as the granulocytosis or thrombocytosis observed in naïve Crebbp+/- mice or in ~25% of unfractionated Crebbp+/- BM transplants.